Prestige Biologics Co., Ltd. (KOSDAQ:334970)

Prestige Biologics Statistics

Total Valuation

KOSDAQ:334970 has a market cap or net worth of KRW 248.42 billion. The enterprise value is 338.30 billion.

Market Cap	248.42B
Enterprise Value	338.30B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:334970 has 77.75 million shares outstanding. The number of shares has increased by 20.50% in one year.

Current Share Class	77.75M
Shares Outstanding	77.75M
Shares Change (YoY)	+20.50%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	20.23%
Owned by Institutions (%)	0.06%
Float	27.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.82
PB Ratio	1.84
P/TBV Ratio	1.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.32
EV / Sales	26.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.38

Financial Position

The company has a current ratio of 0.40, with a Debt / Equity ratio of 0.68.

Current Ratio	0.40
Quick Ratio	0.06
Debt / Equity	0.68
Debt / EBITDA	n/a
Debt / FCF	-3.89
Interest Coverage	-3.86

Financial Efficiency

Return on equity (ROE) is -26.56% and return on invested capital (ROIC) is -8.93%.

Return on Equity (ROE)	-26.56%
Return on Assets (ROA)	-7.52%
Return on Invested Capital (ROIC)	-8.93%
Return on Capital Employed (ROCE)	-20.06%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.04
Inventory Turnover	1.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.57% in the last 52 weeks. The beta is 0.91, so KOSDAQ:334970's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-46.57%
50-Day Moving Average	3,598.60
200-Day Moving Average	4,118.55
Relative Strength Index (RSI)	28.63
Average Volume (20 Days)	134,376

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:334970 had revenue of KRW 12.53 billion and -27.47 billion in losses. Loss per share was -372.51.

Revenue	12.53B
Gross Profit	-15.98B
Operating Income	-33.68B
Pretax Income	-27.47B
Net Income	-27.47B
EBITDA	-20.60B
EBIT	-33.68B
Loss Per Share	-372.51

Balance Sheet

The company has 1.58 billion in cash and 91.46 billion in debt, giving a net cash position of -89.88 billion or -1,155.96 per share.

Cash & Cash Equivalents	1.58B
Total Debt	91.46B
Net Cash	-89.88B
Net Cash Per Share	-1,155.96
Equity (Book Value)	135.20B
Book Value Per Share	1,738.89
Working Capital	-61.57B

Cash Flow

In the last 12 months, operating cash flow was -18.31 billion and capital expenditures -5.23 billion, giving a free cash flow of -23.53 billion.

Operating Cash Flow	-18.31B
Capital Expenditures	-5.23B
Free Cash Flow	-23.53B
FCF Per Share	-302.67

Margins

Gross margin is -127.53%, with operating and profit margins of -268.74% and -219.17%.

Gross Margin	-127.53%
Operating Margin	-268.74%
Pretax Margin	-219.17%
Profit Margin	-219.17%
EBITDA Margin	-164.35%
EBIT Margin	-268.74%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:334970 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.50%
Shareholder Yield	n/a
Earnings Yield	-11.06%
FCF Yield	-9.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:334970 has an Altman Z-Score of -0.33 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.33
Piotroski F-Score	4